Cargando…
Potentiation of the Vincristine Effect on P388 Mouse Leukemia Cells by a Newly Synthesized Dihydropyridine Analogue, PAK‐200
A newly synthesized dihydropyridine analogue, 2‐[benzyl(phenyl)amino]ethyl 1,4‐dihydrb‐2,6‐dimethyl‐5‐(5,5‐dimethyl‐2‐oxo‐l,3,2‐dioxaphosphorinan‐2‐yl)‐l‐(2‐morpholinoethyl)‐4‐(3‐nitrophen‐yl)‐3‐pyridinecarboxylate (PAK‐200), at 1 μM completely reversed the resistance to vincristine in vincristine‐r...
Autores principales: | Shudo, Norimasa, Fujii, Ryu‐ichi, Matsumoto, Tamotsu, Mizoguchi, Tetsuro, Seto, Kiyotomo, Sakoda, Ryozo, Akiyama, Shin‐ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918971/ https://www.ncbi.nlm.nih.gov/pubmed/1429198 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02015.x |
Ejemplares similares
-
Reversal by Two Dihydropyridine Compounds of Resistance to Multiple Anticancer Agents in Mouse P388 Leukemia in vivo and in vitro
por: Kiue, Akira, et al.
Publicado: (1990) -
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines
por: Vanhoefer, U, et al.
Publicado: (1999) -
Antimicrobial Activity of Novel C2-Substituted 1,4-Dihydropyridine Analogues
por: Olejníková, Petra, et al.
Publicado: (2014) -
1,4-Dihydropyridine Derivatives: Dihydronicotinamide Analogues—Model Compounds Targeting Oxidative Stress
por: Velena, Astrida, et al.
Publicado: (2016) -
Vincristine‐resistant Human Cancer KB Cell Line and Increased Expression of Multidrug‐resistance Gene
por: Kohno, Kimitoshi, et al.
Publicado: (1988)